Jack Quaid is amazed at how the Oppenheimer cast still remains connected after nearly two years after the film first ...

EQT (NYSE:EQT – Get Free Report) had its target price raised by Citigroup from $51.00 to $60.00 in a research report issued ...

AGCO (NYSE:AGCO – Get Free Report) had its price target upped by research analysts at Citigroup from $95.00 to $98.00 in a ...

David Bohm was a brilliant physicist. In the latter part of World War II, when he was just a graduate student, his PhD ...

Leaders from Pennant Group, Inc. (Nasdaq: PNTG), the parent company of a network of home health, hospice, and senior living ...

From checking in amid the L.A. fires to supporting each other's careers, Quaid says the star-studded cast still chats ...

Christopher Nolan doesn't need an image to maintain; from Following (1998) to Oppenheimer (2023), fans know what's in store ...

A fresh set of headlines may have given investors fresh reasons to sell Tesla, among them competitive news out of China and ...

On the other hand, US mid-cap stocks have returned 9.3% annually over the past 10 years, with an EPS growth of 9.9% annually ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Hold rating on Cartesian Therapeutics (RNAC – Research Report). The ...

Remembering Pat, a good friend from Omaha, Neb.

Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...